It's been an up-and-down year for NxStage Medical (NASDAQ: NXTM) shareholders. The medical technology company's stock dropped over 35% by mid-February only to rebound strongly over the past three ...
NxStage Medical, Inc. NXTM recently announced the regulatory approval of its System One platform by the FDA for solo home hemodialysis treatment. The company has also announced that it will provide ...
LAWRENCE, Mass., Feb. 19, 2013 /PRNewswire/ -- NxStage(R) Medical, Inc. , a leading manufacturer of innovative dialysis products, today announced CE Mark approval for nocturnal home hemodialysis with ...
LAWRENCE, Mass., Dec. 11, 2017 /CNW/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, celebrates the achievement of over five thousand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback